BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29923200)

  • 1. EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.
    Hong G; Kuek V; Shi J; Zhou L; Han X; He W; Tickner J; Qiu H; Wei Q; Xu J
    J Cell Physiol; 2018 Nov; 233(11):8526-8537. PubMed ID: 29923200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFL7 is expressed in bone microenvironment and promotes angiogenesis via ERK, STAT3, and integrin signaling cascades.
    Chim SM; Kuek V; Chow ST; Lim BS; Tickner J; Zhao J; Chung R; Su YW; Zhang G; Erber W; Xian CJ; Rosen V; Xu J
    J Cell Physiol; 2015 Jan; 230(1):82-94. PubMed ID: 24909139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor-like domain 7 promotes cell invasion and angiogenesis in pancreatic carcinoma.
    Shen X; Han Y; Xue X; Li W; Guo X; Li P; Wang Y; Li D; Zhou J; Zhi Q
    Biomed Pharmacother; 2016 Feb; 77():167-75. PubMed ID: 26796281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network.
    Huang C; Yuan X; Wan Y; Liu F; Chen X; Zhan X; Li X
    Int J Clin Exp Pathol; 2014; 7(3):1022-31. PubMed ID: 24696719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting EGFL7 expression through RNA interference suppresses renal cell carcinoma growth by inhibiting angiogenesis.
    Xu HF; Chen L; Liu XD; Zhan YH; Zhang HH; Li Q; Wu B
    Asian Pac J Cancer Prev; 2014; 15(7):3045-50. PubMed ID: 24815445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor-like domain 7 promotes migration and invasion of human trophoblast cells through activation of MAPK, PI3K and NOTCH signaling pathways.
    Massimiani M; Vecchione L; Piccirilli D; Spitalieri P; Amati F; Salvi S; Ferrazzani S; Stuhlmann H; Campagnolo L
    Mol Hum Reprod; 2015 May; 21(5):435-51. PubMed ID: 25667199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidermal growth factor-like domain 7 promotes endothelial cell migration and angiogenesis by activating ERK signaling pathway].
    Cao Y; Lyu Q
    Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):270-3. PubMed ID: 25975912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of EGFL7 in human cancers: A review.
    de Oliveira C; Gonçalves PG; Bidinotto LT
    J Cell Physiol; 2023 Aug; 238(8):1756-1767. PubMed ID: 37490307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts.
    Liakouli V; Cipriani P; Di Benedetto P; Panzera N; Ruscitti P; Pantano I; Berardicurti O; Carubbi F; Esteves F; Mavria G; Del Galdo F; Giacomelli R
    Sci Rep; 2019 Mar; 9(1):4589. PubMed ID: 30872612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different expression of VEGF and EGFL7 in human hepatocellular carcinoma.
    Campagnolo L; Telesca C; Massimiani M; Stuhlmann H; Angelico M; Lenci I; Manzia TM; Tariciotti L; Lehmann G; Baiocchi L
    Dig Liver Dis; 2016 Jan; 48(1):76-80. PubMed ID: 26542361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro inhibitory effect of EGFL7-RNAi on endothelial angiogenesis in glioma.
    Li Q; Wang AY; Xu QG; Liu DY; Xu PX; Yu D
    Int J Clin Exp Pathol; 2015; 8(10):12234-42. PubMed ID: 26722408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.
    Huang C; Yuan X; Li Z; Tian Z; Zhan X; Zhang J; Li X
    Int J Clin Exp Pathol; 2014; 7(3):1077-84. PubMed ID: 24696724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma.
    Wang FY; Kang CS; Wang-Gou SY; Huang CH; Feng CY; Li XJ
    Cancer Lett; 2017 Jan; 384():9-18. PubMed ID: 27725228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-126 and miR-126*: new players in cancer.
    Meister J; Schmidt MHH
    ScientificWorldJournal; 2010 Oct; 10():2090-100. PubMed ID: 20953557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the Epidermal Growth Factor-like Domain 7 and Inhibition of Migration and Epithelial-Mesenchymal Transition in Human Pancreatic Cancer PANC-1 Cells.
    Wang YL; Dong FL; Yang J; Li Z; Zhi QM; Zhao X; Yang Y; Li DC; Shen XC; Zhou J
    Asian Pac J Cancer Prev; 2015; 16(9):4065-9. PubMed ID: 25987088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell RNA sequencing reveals differential expression of EGFL7 and VEGF in giant-cell tumor of bone and osteosarcoma.
    Feleke M; Feng W; Song D; Li H; Rothzerg E; Wei Q; Kõks S; Wood D; Liu Y; Xu J
    Exp Biol Med (Maywood); 2022 Jul; 247(14):1214-1227. PubMed ID: 35695550
    [No Abstract]   [Full Text] [Related]  

  • 17. Egfl7 Represses the Vasculogenic Potential of Human Endothelial Progenitor Cells.
    d'Audigier C; Susen S; Blandinieres A; Mattot V; Saubamea B; Rossi E; Nevo N; Lecourt S; Guerin CL; Dizier B; Gendron N; Caetano B; Gaussem P; Soncin F; Smadja DM
    Stem Cell Rev Rep; 2018 Feb; 14(1):82-91. PubMed ID: 28980146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.
    Zhang Y; Wang X; Xu B; Wang B; Wang Z; Liang Y; Zhou J; Hu J; Jiang B
    Oncol Rep; 2013 Oct; 30(4):1976-84. PubMed ID: 23900443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFL7 ligates αvβ3 integrin to enhance vessel formation.
    Nikolic I; Stankovic ND; Bicker F; Meister J; Braun H; Awwad K; Baumgart J; Simon K; Thal SC; Patra C; Harter PN; Plate KH; Engel FB; Dimmeler S; Eble JA; Mittelbronn M; Schäfer MK; Jungblut B; Chavakis E; Fleming I; Schmidt MHH
    Blood; 2013 Apr; 121(15):3041-50. PubMed ID: 23386126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFL7 enhances surface expression of integrin α
    Dudvarski Stanković N; Bicker F; Keller S; Jones DT; Harter PN; Kienzle A; Gillmann C; Arnold P; Golebiewska A; Keunen O; Giese A; von Deimling A; Bäuerle T; Niclou SP; Mittelbronn M; Ye W; Pfister SM; Schmidt MHH
    EMBO Mol Med; 2018 Sep; 10(9):. PubMed ID: 30065025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.